MetaOptics Secures Up to $10 Million Investment Facility from White Lion Capital
Singapore-based MetaOptics has secured an investment facility of up to US$10 million from White Lion Capital, its first U.S. institutional investor, to onshore metalens technology.
MetaOptics Ltd, a semiconductor optics company based in Singapore, has announced securing an investment facility of up to US$10 million from White Lion Capital. This represents the company's first institutional investment from a U.S. investor.
The funding is intended to support MetaOptics' strategic objective of bringing its metalens technology manufacturing onshore in the United States. The move aims to address growing demand and enhance supply chain security within North America.
MetaOptics specializes in advanced semiconductor optics, focusing on the development of metalenses. These flat optical components are designed to replace traditional curved lenses and have potential applications in areas such as augmented and virtual reality devices, cameras, and medical equipment.
The company, listed on the Catalist exchange under the ticker 9MT, plans to utilize this facility to accelerate product development and expand its manufacturing capabilities within the U.S.